NCT00689312 is a Phase 3 clinical trial of Enfalyte in Gastroenteritis, sponsored by The Hospital for Sick Children.

Who is sponsoring NCT00689312?

NCT00689312 is sponsored by The Hospital for Sick Children.

What drugs are being tested in NCT00689312?

Interventions in NCT00689312: Enfalyte, Pediatric Electrolyte, Pedialyte.

What condition does NCT00689312 study?

NCT00689312 studies Gastroenteritis.

Is NCT00689312 still recruiting?

NCT00689312 is currently completed. Last updated 16 April 2018.

Last reviewed 2018-04-16 · How we verify

NCT00689312

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Palatability of Oral Rehydration Solutions

Completed Phase 3 Last updated 16 April 2018

What this trial tests

Phase 3 trial testing Enfalyte in Gastroenteritis in 66 participants. Completed in 1 August 2008.

Timeline

1 May 2008

Primary endpoint
1 August 2008

1 August 2008

Quick facts

Lead sponsor	The Hospital for Sick Children
Phase	Phase 3
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	quadruple
Primary purpose	other
Enrollment	66
Start date	1 May 2008
Primary completion	1 August 2008
Estimated completion	1 August 2008
Sites	1 location across Canada

Drugs / interventions tested

Enfalyte — full drug profile →
Pediatric Electrolyte — full drug profile →
Pedialyte — full drug profile →

Conditions studied

Gastroenteritis — all drugs for Gastroenteritis →

Sponsor

The Hospital for Sick Children

Who can join

Adults 5 to 10, any sex, with Gastroenteritis. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Mean taste scores for Pedialyte, Pediatric Electrolyte, and Enfalyte.
Time frame: Immediately following consumption of each solution.

Sponsor's own description

The primary objective of this study is to compare the mean taste scores for three fruit flavored oral rehydration solutions in children aged 5-10 years old. The secondary objective is to compare the proportions of children who indicate a taste preference for one of the solutions.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Assessing the palatability of oral rehydration solutions in school-aged children: a randomized crossover trial.
Freedman SB, Cho D, Boutis K, Stephens D, et al · · 2010 · cited 15× · PMID 20679159 · DOI 10.1001/archpediatrics.2010.129

Verify or expand the search:

Other recruiting trials for Gastroenteritis

Currently open trials in the same condition.

NCT07285785 — Rifaximin 200 mg Plus Oral Rehydration vs Oral Rehydration Alone in Children With Acute Diarrhea · Phase 4 · recruiting
NCT06579170 — Burden of Recreational Water Illness Due to Exposure to Cyanobacteria and Their Toxins in Freshwater Beaches in Canada · active not recruiting
NCT05870150 — Challenge Non-Typhoidal Salmonella (CHANTS) Study · NA · active not recruiting
NCT04471493 — Pediatric and Ambulatory Research in Infectious Diseases · recruiting

Other The Hospital for Sick Children trials

Trials by the same sponsor.

NCT07454681 — MRI Assessment of Lung Airways in Cystic Fibrosis: Evaluate MRI's Ability to Detect Changes in Airway Structure . · not yet recruiting
NCT07452575 — 3D Ultrasound in Hemophilic Ankles · NA · not yet recruiting
NCT07508826 — AI-assisted Endotracheal Intubation · NA · not yet recruiting
NCT07345819 — Dexamethasone vs. Placebo in Children and Youth Hospitalized for Orbital Cellulitis · NA · not yet recruiting
NCT07497178 — MRgFUS for Childhood Epilepsy · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00689312 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The Hospital for Sick Children
Last refreshed: 16 April 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00689312.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing